MENU
+Compare
ALT
Stock ticker: NASDAQ
AS OF
Jan 14 closing price
Price
$4.18
Change
+$0.17 (+4.24%)
Capitalization
436.15M

ALT Altimmune Forecast, Technical & Fundamental Analysis

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALT with price predictions
Jan 13, 2026

ALT in downward trend: price dove below 50-day moving average on December 19, 2025

ALT moved below its 50-day moving average on December 19, 2025 date and that indicates a change from an upward trend to a downward trend. In of 33 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for ALT crossed bearishly below the 50-day moving average on December 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALT entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALT's RSI Indicator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where ALT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 06, 2026. You may want to consider a long position or call options on ALT as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALT just turned positive on January 12, 2026. Looking at past instances where ALT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

ALT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.350) is normal, around the industry mean (30.106). P/E Ratio (0.000) is within average values for comparable stocks, (51.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.888). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. ALT's P/S Ratio (10000.000) is very high in comparison to the industry average of (322.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALT is expected to report earnings to rise 18.62% to -24 cents per share on March 26

Altimmune ALT Stock Earnings Reports
Q4'25
Est.
$-0.25
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -20 cents, beating the estimate of -27 cents. With 3.27M shares outstanding, the current market capitalization sits at 436.15M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
910 Clopper Road
Phone
+1 240 654-1450
Employees
59
Web
https://www.altimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNSX78.350.90
+1.16%
Janus Henderson Global Life Sciences S
MSVOX6.760.03
+0.45%
Morgan Stanley Vitality Portfolio R6
ATECX149.48-0.36
-0.24%
AB Sustainable Global Thematic C
APHDX20.62-0.10
-0.48%
Artisan Global Discovery Institutional
BRWVX27.57-0.38
-1.36%
MFS Blended Research Growth Eq R6

ALT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-0.99%
ACHV - ALT
46%
Loosely correlated
-2.47%
INDP - ALT
45%
Loosely correlated
-3.17%
KROS - ALT
39%
Loosely correlated
+3.28%
AMRN - ALT
38%
Loosely correlated
-2.57%
RXRX - ALT
35%
Loosely correlated
-2.49%
More